News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ipsen (IPN.PA) US Awards up to $300,000 for Dystonia Fellowship Grants in 2013



10/23/2012 9:20:30 AM

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen’s (Euronext: IPN; ADR: IPSEY) North American Operations subsidiary, Ipsen Biopharmaceuticals Inc., today announced its commitment to award up to $300,000 in grants to the Dystonia Medical Research Foundation’s (DMRF) 2013 Clinical Fellowship Training Program. The Company’s contribution will provide up to four one-year fellowship grants, at $75,000 each, to address current challenges for physicians in the evaluation and treatment of dystonia – a neurological movement disorder that causes involuntary muscle spasms.

Read at BioSpace.com

Related News

comments powered by Disqus
Ipsen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES